Mateusz Kaczmarek

Mateusz Kaczmarek is a financial and technology journalist at TS2.tech, covering stocks, artificial intelligence, semiconductors and global market developments. A graduate of the Poznań University of Economics and Business, he previously worked in financial analysis before moving into business journalism. His reporting focuses on technology companies, market trends and the forces shaping global investment markets. Follow Mateusz Kaczmarek on Google News.

Acrivon Therapeutics (ACRV): Precision Oncology Game-Changer or Overhyped Biotech Bet?

Acrivon Therapeutics (ACRV): Precision Oncology Game-Changer or Overhyped Biotech Bet?

Acrivon Therapeutics is a Boston-area biotech founded in 2018, emerging with a mission to revolutionize cancer treatment through precision medicinestockanalysis.com. The company’s name “Acrivon” is derived from “accurate” or “precision,” reflecting its core approach: develop targeted oncology drugs hand-in-hand with diagnostics that pinpoint the patients who will respond. Acrivon’s proprietary platform, AP3, lies at the heart of this strategy. Using proteomics and AI tools, AP3 measures the activity of myriad proteins and signaling pathways inside tumor cells in their native state, rather than just analyzing DNA mutationsglobenewswire.comglobenewswire.com. This allows Acrivon to create drug-specific “OncoSignature” tests – essentially companion diagnostics that predict whether a patient’s tumor is susceptible to a given drugstockanalysis.comstockanalysis.com. It’s a novel twist on precision oncology: instead of the traditional focus on genetic markers, Acrivon’s proteomic signatures aim to capture real-time tumor biology to guide therapynasdaq.comglobenewswire.com.
NIO Stock Skyrockets on Record Sales and Bold Moves – Can the Rally Last?

NIO Stock Skyrockets on Record Sales and Bold Moves – Can the Rally Last?

NIO’s stock has been on a notable upswing heading into November 2025. Shares closed at $7.25 on October 31, 2025 – a multi-month high – after jumping over 3% in a single day following the latest delivery reportstockinvest.us. This capped a strong week; NIO gained roughly 5.1% over the last week of October, even though it was still down a few percent over the full monthsimplywall.st. The late-October bounce reflects renewed investor enthusiasm around the company’s record sales figures and growth trajectory.
TGE Stock’s Wild Ride: Why The Generation Essentials Group Is Making Headlines in Nov 2025

TGE Stock’s Wild Ride: Why The Generation Essentials Group Is Making Headlines in Nov 2025

TGE’s stock has experienced a rollercoaster in recent days, capturing investors’ attention. In the final week of October 2025, shares entered a freefall: between October 27 and October 31 the price plunged from highs near $1.89 to a low of $0.7777 intraday on Oct 31 Stockstotrade. The October 31 session was especially dramatic – TGE opened around $1.79 but collapsed over 50%, hitting that record low of $0.78 before closing at $1.01 Stockstotrade Stockstotrade. This marked a single-day drop of ~54%, capping a multi-day slide in which the stock lost roughly 40% of its value for the week Stockstotrade.
3 November 2025
IDEXX Laboratories (IDXX): Inside the Pet Diagnostics Leader’s 2025 Breakout 🚀

IDEXX Laboratories (IDXX): Inside the Pet Diagnostics Leader’s 2025 Breakout 🚀

IDEXX Laboratories, Inc. is a veterinary diagnostics and life sciences company that develops, manufactures, and sells products and services for animal health and water testing in over 175 countries Pestel Analysis Pestel Analysis. Founded in 1983 and headquartered in Maine, IDEXX has grown into the dominant player in pet healthcare diagnostics, as well as a significant provider in livestock/poultry and water microbiology testing. The company operates through three main business segments Wikipedia:
3 November 2025
Rani Therapeutics (RANI) Stock Skyrockets on Biotech Breakthrough: Inside the Surge and What’s Next

Rani Therapeutics (RANI) Stock Skyrockets on Biotech Breakthrough: Inside the Surge and What’s Next

Rani Therapeutics’ stock price has been on a tear in late 2025, turning heads in the biotech investing community. After languishing under $1 for most of the year, RANI exploded upward in October. It closed on Oct 31 at $2.20, up +51.7% in one dayfinviz.com on massive volume. In fact, over the past month RANI has climbed about 335%finviz.com. Just a few weeks ago in early October it was trading around 50–60 cents; by the first week of November it’s oscillating in the mid-$2s. As of Nov 3, the stock is indicated around $2.50futunn.com – a stunning short-term gain, though still a far cry from its IPO price.
Dell Stock Skyrockets on AI Boom – Price Surge, Key News & 2025 Outlook

Dell Stock Skyrockets on AI Boom – Price Surge, Key News & 2025 Outlook

Dell Technologies stock is trading around $162 per share as of Nov. 3, 2025, near its 52-week high after a massive rally fueled by booming demand for AI serversmarketbeat.com. Shares have more than doubled in the past year and are up roughly 35% year-to-date, far outperforming the S&P 500 and most tech peersmarketbeat.com. In the last few days, major news – including a $5.8 billion AI hardware deal tied to Microsoft – has driven the stock higherreuters.com. Analysts remain bullish, citing Dell’s raised growth forecasts and strong positioning in enterprise AI, while company executives highlight surging demand for Dell’s infrastructure solutions. Below we break down the current price trend, recent news, financial performance, expert commentary, competitive landscape, and the short- and long-term outlook for Dell stock.
ALPS Group (NASDAQ: ALPS) Stock’s Wild Debut – Biotech Unicorn’s SPAC Merger Sparks Volatile Trading

ALPS Group (NASDAQ: ALPS) Stock’s Wild Debut – Biotech Unicorn’s SPAC Merger Sparks Volatile Trading

Sources: Financial data from Yahoo Finance/Refinitivreuters.comreuters.com and company filings; GlobeNewswire press releaseglobenewswire.comglobenewswire.com; Reuters news reportreuters.com; Bernama interview with CEObernama.combernama.com; Stock analysis sites and SEC filings for market cap and float detailsfinviz.comstocktitan.net. All statements and quotes are cited from these sources.
3 November 2025
Berkshire Hathaway’s Next Act: Trillion-Dollar BRK-B, Buffett’s Farewell & 2025 Forecasts

Berkshire Hathaway’s Next Act: Trillion-Dollar BRK-B, Buffett’s Farewell & 2025 Forecasts

Berkshire Hathaway’s Class B stock trades around $477–$480 as of early November 2025stockinvest.us. The share price has eased off about 5% since mid-October, when it briefly crossed the $500 mark before pulling backstockinvest.us. Year-to-date, BRK-B is up roughly 8–9% in 2025, which means it has underperformed the S&P 500tipranks.com. Berkshire’s stock had been at record highs earlier in the year, but it fell back after CEO Warren Buffett announced his retirement plans in May – since that news, the stock has lagged the broader market’s rallytipranks.combenzinga.com.
Datavault AI (DVLT) Stock Skyrockets on AI Frenzy – Key Facts & Future Outlook

Datavault AI (DVLT) Stock Skyrockets on AI Frenzy – Key Facts & Future Outlook

Datavault AI Inc. is a young technology company at the intersection of artificial intelligence, blockchain, and data monetization. Its mission is to help organizations turn underutilized data into valuable assets. To do this, Datavault provides a cloud-based platform that combines high-performance computing and Web 3.0 data management. In practice, the company’s software enables clients to securely manage their data, “tokenize” data into digital assets, and create digital twins of real-world datastocktitan.netstocktitan.net. This allows the data to be bought, sold, or licensed on exchanges, potentially unlocking new revenue streams for data owners.
AMTD Digital (HKD) Skyrockets 180% on 1,085% Revenue Surge – Meme-Stock Mania 2.0 or Sustainable Comeback?

AMTD Digital (HKD) Skyrockets 180% on 1,085% Revenue Surge – Meme-Stock Mania 2.0 or Sustainable Comeback?

AMTD Digital Inc. is a subsidiary of the AMTD Group conglomerate and part of a broader family that includes parent AMTD IDEA Group. Founded in 2019 and initially based in Hong Kong, AMTD Digital positioned itself as a “one-stop” digital solutions platform. Its original business lines span digital financial services, the AMTD SpiderNet ecosystem, digital media, content & marketing, and digital investments in tech startupsreuters.comchartmill.com. The company capitalized on AMTD Group’s fintech roots – leveraging various financial licenses in Asia – while also investing in content and digital marketing capabilities.
3 November 2025
Micron’s AI-Fueled Stock Surge: Record Earnings, Rallying Shares & What’s Next for MU

Micron’s AI-Fueled Stock Surge: Record Earnings, Rallying Shares & What’s Next for MU

Micron Technology, Inc. is a leading semiconductor manufacturer specializing in memory and data storage chips. Its product portfolio includes dynamic random access memory chips – used in PCs, servers, and smartphones – and NAND flash memory for data storage in devices like solid-state drives. Micron is also at the forefront of new memory technologies such as High-Bandwidth Memory, a specialized high-speed DRAM used in advanced AI accelerators and graphics processorsreuters.com. These memory products are critical components in modern computing infrastructure, from cloud data centers to personal gadgets.
FuboTV’s Big Score: Disney Hulu Deal and Surprise Profit Spark Stock Surge

FuboTV’s Big Score: Disney Hulu Deal and Surprise Profit Spark Stock Surge

FuboTV’s stock is on the move after a one-two punch of strong earnings and a transformational Disney partnership. As of November 3, 2025, FUBO shares traded around $3.90, up roughly 5% from the prior closeinvesting.com. The latest Q3 earnings surprise – featuring better-than-expected revenue and a swing to adjusted profit – sent investors piling in, reflecting newfound optimism about Fubo’s direction. This continues a dramatic run for FUBO stock in 2025, which has climbed nearly 200% year-to-date as anticipation built for Fubo’s merger with Disney’s Hulu Live TV unitfinanchill.comfinanchill.com.
3 November 2025
Interstellar Comet 3I/ATLAS Stuns Scientists – Brightening, Blue Glow & Mystery Acceleration

Interstellar Comet 3I/ATLAS Stuns Scientists – Brightening, Blue Glow & Mystery Acceleration

When astronomers spotted a faint new object moving rapidly through the outer solar system in July 2025, they quickly realized it was not an ordinary comet. Its extra-high velocity and open-ended trajectory indicated it was an interstellar interloper – an object arriving from far outside the Sun’s domainscientificamerican.com. Officially designated 3I/ATLAS, this comet has since commanded the full attention of the astronomical community. “We’ve never had an object like this to study before,” as one scientist marveledtheguardian.com.
Nebius: The 350% Soaring AI Cloud Stock Taking on Amazon – What Investors Should Know

Nebius: The 350% Soaring AI Cloud Stock Taking on Amazon – What Investors Should Know

Nebius Group’s journey is unconventional. The company originated as Yandex N.V., the Netherlands-based parent of Russia’s largest tech firm. In 2022, Yandex’s Nasdaq-listed shares were suspended due to sanctions after Russia’s Ukraine invasion Wikipedia. Fast forward to 2024: Yandex’s founder Arkady Volozh, who had publicly condemned the war, led a dramatic restructuring. Yandex sold off all its Russian businesses to local investors, and the remaining international divisions were reborn as Nebius Group, refocusing entirely on artificial intelligence ventures Wikipedia Wikipedia. In October 2024, the ticker changed from YNDX to NBIS and trading on Nasdaq resumed Wikipedia. The “new” Nebius thus emerged with a clean slate and an ambitious mission in the AI space.
3 November 2025
Google’s $3 Billion AI Bet on a Bitcoin Miner – Cipher Mining’s Q3 Bombshell Deals

Google’s $3 Billion AI Bet on a Bitcoin Miner – Cipher Mining’s Q3 Bombshell Deals

Cipher Mining’s third quarter 2025 financial results underscore a company in transition. Revenue came in at $72 million, more than triple the year-ago quarteretfchannel.com. This jump was largely thanks to new mining capacity like the Black Pearl site ramping up Bitcoin production and efficiencyetfchannel.com. Despite the rapid growth, the company recorded a modest net loss of $3 million under GAAP accountingstocktitan.net. Notably, after adjusting for various items, Cipher actually achieved $41 million in adjusted earningsstocktitan.net, reflecting the strong underlying profitability of its operations.
Kforce Stock Hits New Low as Big Investors Buy In Ahead of Q3 Results

Kforce Stock Hits New Low as Big Investors Buy In Ahead of Q3 Results

Kforce’s Steep Slide: It’s been a rough year for Kforce shareholders. The stock has lost well over half its value from its highs as hiring in the tech sector cooled and recession fears weighed on corporate spending. In mid-October, Kforce shares hit a new 12-month low, dipping to about $24.62marketbeat.com, after an analyst downgrade added to the pessimism. Even after a modest bounce, the stock is only around the mid-$25 level in early November – a far cry from the $60+ prices seen within the past yearmarketbeat.com. This plunge reflects both company-specific struggles and broader market headwinds. As evidence, an index of professional staffing stocks is down only a few percent over the last month, yet Kforce tumbled nearly 16% in that timeindexbox.io, indicating investors have singled it out for harsher punishment.
Off-the-Shelf CAR-T Triumph: Caribou’s Breakthrough Results Spark Stock Surge

Off-the-Shelf CAR-T Triumph: Caribou’s Breakthrough Results Spark Stock Surge

Caribou Biosciences – a clinical-stage biotech focusing on genome-edited cell therapies – stunned the biotech world with new data on November 3, 2025, showcasing that its off-the-shelf CAR-T cell treatments can achieve remission rates on par with personalized CAR-T therapiesstatnews.com. In an early-morning webcast, Caribou revealed Phase 1 trial outcomes from two programs: vispa-cel for B-cell lymphoma and CB-011 for multiple myelomatipranks.com. The headline: patients with aggressive blood cancers, who had exhausted other options, responded remarkably well to these donor-derived CAR-T infusions. Caribou reported multiple complete and durable remissions in both trials, exceeding what many thought possible for an “off-the-shelf” approachstatnews.com.
Election Day 2025: What’s Open, What’s Closed – Banks, Mail, Shipping and Surprises

Election Day 2025: What’s Open, What’s Closed – Banks, Mail, Shipping and Surprises

Election Day in the United States falls on Tuesday, November 4, 2025. Unlike holidays such as Veterans Day or Memorial Day, Election Day is not a federal holiday, so there is no nationwide work stoppagehindustantimes.com. On the federal level, government offices, agencies, and services remain open on their usual schedules. For most Americans, it’s a normal workday with the expectation that voting is done in between work or before/after hours.
Ondas Holdings (ONDS) Soars 1000% on Drone Frenzy – Bubble or Breakthrough?

Ondas Holdings (ONDS) Soars 1000% on Drone Frenzy – Bubble or Breakthrough?

Ondas Holdings – a Massachusetts-based developer of private wireless networks and autonomous drone systems for industrial and defense markets – has seen its stock go on a breathtaking rollercoaster this year. After trading as a penny stock under $1 in early 2025, ONDS rocketed to an intraday high of $11.70 by October, a 1,000%+ surge driven by investor fervor for defense-tech plays. By late October it plunged ~45% off that peak, settling around the mid-$6s. As of November 2, 2025, ONDS is hovering near $6.4 per share – a far cry from its highs, yet still “up nearly 10× year-on-year” and about +150–296% year-to-date. In other words, Ondas has transformed from an obscure micro-cap into one of the market’s most explosive small-cap performers.
1 73 74 75 76 77 164

Stock Market Today

  • HSBC Casts Doubt on SpaceX Stock Price Amid Rocket Milestones
    July 26, 2026, 1:59 AM EDT. While HSBC recognises SpaceX's success with its rocket advancements, the bank expresses reservations about the stock's market valuation, indicating that the share price may not account for risks that extend past the performance of the rockets.